Thanks for the analysis. Can you do the same, but omit FY2016...

First 66 Last

Share
Profile

Follow
JayWin

1,990 Posts.

123

14/06/17

15:22

Post #: 25271214
Share

Originally posted by JoeGambler ↑

I think if you believe in the theme of the rise, and rise of the Asian middle classes and their desire for quality western products, hang in there!

These themes take time to play out. The regulatary hit on the Diagou 'grey market' was tough, though direct export is what the business should aspire to in the lonng term anyways. This is in contrast to people walking into Chemist Warehouse and buying packs of fish oil and shipping it to china for 3-4 times the price.

The current share price is significantly discounting BKL's ability to grow into Asia, which is actually more proven than any other business in this space availiable on the ASX.

Consensus on Commsec is EPS $3.548 FY17 (24.5 PE) and EPS $4.60 in FY18 (19 PE) .

Over the last 10 years the company has achieved 20.9% earnings growth p/a.

Over the last 10 years management have achieved an average of 35% return on equity.

I understand this will take a hit factoring in the pull back this FY, due to excess inventory ect, but the quality of the business is there to be seen.

I think taking a short sighted view on a long term theme and quality business is the opposite to what investing should be.

Thanks.

Expand

Thanks for the analysis. Can you do the same, but omit FY2016 results and see what earnings growth and ROE you get?

That will show us a better picture of actual growth, ignoring that crazy year.

BKL Price at posting: $88.43 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

There are more pages in this discussion • 56 more messages in this thread...

First 66 Last

Add BKL (ASX) to my watchlist

Thanks for the analysis. Can you do the same, but omit FY2016...

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado